story of the week
Timing of High-Efficacy Therapy for Multiple Sclerosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Timing of High-Efficacy Therapy for Multiple Sclerosis: A Retrospective Observational Cohort Study
Lancet Neurol 2020 Apr 01;19(4)307-316, A He, B Merkel, JWL Brown, L Zhovits Ryerson, I Kister, CB Malpas, S Sharmin, D Horakova, E Kubala Havrdova, T Spelman, G Izquierdo, S Eichau, M Trojano, A Lugaresi, R Hupperts, P Sola, D Ferraro, J Lycke, F Grand'Maison, A Prat, M Girard, P Duquette, C Larochelle, A Svenningsson, T Petersen, P Grammond, F Granella, V Van Pesch, R Bergamaschi, C McGuigan, A Coles, J Hillert, F Piehl, H Butzkueven, T KalincikFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.